Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$878K Buy
2,325
+37
+2% +$15.8K 0.13% 101
2025
Q4
$979K Buy
2,288
+149
+7% +$64.9K 0.13% 103
2025
Q3
$958K Buy
2,139
+24
+1% +$10.9K 0.13% 102
2025
Q2
$1.03M Buy
2,115
+86
+4% +$49K 0.14% 101
2025
Q1
$1.25M Buy
2,029
+21
+1% +$11.9K 0.19% 87
2024
Q4
$1.06M Buy
2,008
+44
+2% +$24.8K 0.15% 102
2024
Q3
$1.18M Sell
1,964
-16
-0.8% -$9.07K 0.17% 94
2024
Q2
$1.14M Sell
1,980
-244
-11% -$140K 0.17% 88
2024
Q1
$1.43M Sell
2,224
-2
-0.1% -$1.22K 0.22% 74
2023
Q4
$1.33M Buy
2,226
+33
+2% +$18.5K 0.21% 73
2023
Q3
$1.14M Buy
2,193
+42
+2% +$21.8K 0.22% 72
2023
Q2
$1.16M Sell
2,151
-168
-7% -$91.8K 0.22% 73
2023
Q1
$1.25M Buy
2,319
+10
+0.4% +$5.1K 0.25% 65
2022
Q4
$1.14M Sell
2,309
-115
-5% -$56K 0.23% 72
2022
Q3
$1.16M Buy
+2,424
New +$1.17M 0.24% 72

Other funds holding CHE

CIM LLC's CHE Position: Q1 2026 in Review

CIM LLC increased its Chemed (CHE) stake by 1.6% in Q1 2026, buying an estimated $15.8K and bringing the position to 2,325 shares worth $878K. The position accounts for 0.13% of the portfolio, ranked #101.

CIM LLC first reported a position in CHE in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.43M in Q1 2024. 489 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

  • CIM LLC held 2,325 shares of Chemed worth $878K as of Q1 2026.
  • CIM LLC bought 37 Chemed shares in Q1 2026, an estimated $15.8K.
  • Chemed made up 0.13% of CIM LLC's portfolio in Q1 2026, its #101 holding.
  • CIM LLC first reported a position in Chemed in Q3 2022 and has held it in 15 quarters since.
  • CIM LLC's Chemed position peaked at $1.43M in Q1 2024.
  • 489 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on CIM LLC's 13F filing for Q1 2026, filed 18 May 2026.